Literature DB >> 55877

Letter: Levamisole in the treatment of cancer.

H W Ward.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 55877     DOI: 10.1016/s0140-6736(76)90400-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Restoration of methotrexate-suppressed oxazolone-induced contact sensitivity with levamisole.

Authors:  D E Griswold; D T Walz
Journal:  Inflammation       Date:  1978-03       Impact factor: 4.092

2.  Condition-dependent immunoregulatory control of contact sensitivity by levamisole.

Authors:  D E Griswold; D T Walz
Journal:  Inflammation       Date:  1977-12       Impact factor: 4.092

3.  Levamisole: evidence for activity on human haemopoietic progenitor cells.

Authors:  J S Senn; C C Lai; G B Price
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.